»
Prue Leith of The Great British Baking Show is the first celebrity to publicly get a COVID-19 vaccine
Prue Leith of The Great British Baking Show is the first celebrity to publicly get a COVID-19 vaccine
Julia NaftulinDec 16, 2020, 01:20 IST
British-South African restaurateur, chef, caterer, television presenter/broadcaster, businesswoman, journalist, cookery writer and novelist Prue Leith attends a photocall during the Edinburgh International Book Festival 2019 on August 10, 2019 in Edinburgh, Scotland.Simone Padovani/Awakening/Getty Images The Great British Baking Show judge Prue Leith is the first known celebrity to get a COVID-19 vaccine.
80-year-old Leith lives in the UK where the first doses of Pfizer s vaccine are being doled out to people over 80.
Letter, 12/15: Today we face a new enemy
journalstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from journalstar.com Daily Mail and Mail on Sunday newspapers.
Product News: EKF introduces accurate quantitative COVID-19 antibody test kit
15 Dec 2020
in vitro diagnostics company, has introduced one of the first tests to precisely measure levels of COVID-19 neutralizing antibodies in individuals. Unlike other antibody tests, the Kantaro COVID-SeroKlir SARS-CoV-2 IgG antibody test kit determines both the presence and specific quantities of human IgG antibodies to the SARS-CoV-2 virus. This enables a broad range of COVID-19 applications, such as delivering vital knowledge for advancing the understanding of protective immunity, assessing vaccine response and accelerating therapeutic treatments.
The high performance quantitative COVID-SeroKlir kit has received FDA Emergency Use Authorization (EUA) and is CE marked. It has demonstrated 98.8% sensitivity and 99.6% specificity for detecting SARS-CoV-2 specific IgG antibodies against two SARS-CoV-2 virus antigens, the full-length spike protein and its receptor-binding domain (RBD). This confirmed
(0)
The combined company will improve access to health economics and outcomes research (HEOR), real world evidence (RWE) and market access services for researchers in the life sciences
Scientist.com, the healthcare industry s leading marketplace for outsourced R&D, announced today it will acquire HealthEconomics.Com, a private US-based company that has spent the last 25 years creating a global Connected Community of scientists and suppliers of health economics and outcomes research (HEOR), real world evidence (RWE) and market access services. The acquisition, expected to be completed in January, reflects Scientist.com s mission to empower and connect scientists worldwide and HealthEconomics.Com s mission to create a connected global community focused on improving patient outcomes.
Pune-based Gennova to begin human trials of its Covid vaccine ‘soon’ For phase 1, we have got two sites where we will be starting enrolment soon, he said, adding that around 120 volunteers will be registered in the first phase at two sites KEM Hospital, Pune and a government hospital in Kolhapur. Updated: December 15, 2020 8:19:38 am
Covid testing in New Delhi on Monday. (Express photo by Praveen Khanna)
Pune-based Gennova Biopharmaceuticals plans to kick off early- to mid-stage human trials of its Covid-19 vaccine candidate “soon”, enrolling around 620 participants across several sites over the next few months.
“We have started the processes. We hope to start phase 1 soon. We will present our phase 1 data to the DCGI (Drug Controller General of India), before starting the second phase, and so the timeline for the trials to be completed will depend on these factors,” said Gennova CEO Dr Sanjay Singh.
vimarsana © 2020. All Rights Reserved.